- FILTERS Advanced
- Product Type
- Application
- Species / Reactivity
- CE / IVD
- Supplier
- EXCLUDE FILTERS
- Application
- Species / Reactivity
- Supplier
| Name | Art no | Species Reactivity | Application | Conjugation | Range | Sensitivity | Size | Price |
|---|---|---|---|---|---|---|---|---|
|
206-P57-58
|
|
|
|
|
|
1 mg
|
||
|
950.640.192
|
human
|
ELISA
|
|
|
|
2 x 96 (pre-coated)
|
||
|
CY-8115
|
human
|
ELISA
|
|
62.5 - 4,000 pg/mL
|
18.9 pg/mL ~
|
96 Assays
|
||
|
CY-8052
|
dog/canine
|
ELISA
|
|
|
better than 163.4 pg/ml of sample.
|
96 Assays
|
||
|
CY-8116
|
human
|
ELISA
|
|
400 - 6,400 pg/mL
|
228 pg/mL -
|
96 Assays
|
||
|
CY-8061
|
human
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the human S100A8/MRP8 concentration. Results exceeding human S100A8/MRP8 level of 500 ng/ml should be repeated with diluted samples.
|
better than 43.4 pg/ml of sample.
|
96 Assays
|
||
|
851.620.001
|
human
|
ELISA
|
|
|
|
1 x 96 Discovery
|
||
|
851.620.015
|
human
|
ELISA
|
|
|
|
15 x 96
|
||
|
861.060.010
|
mouse
|
ELISA
|
|
|
|
10 x 96
|
||
|
861.060.015
|
mouse
|
ELISA
|
|
|
|
15 x 96
|
||
|
AG-45A-0035YTP-KI01
|
human
|
ELISA
|
|
0.39 to 25ng/ml
|
380pg/ml
|
2 x 96 wells
|
||
|
AG-45A-0018YTP-KI01
|
human
|
ELISA
|
|
0.063 to 4ng/ml
|
32pg/ml
|
2 x 96 wells
|
||
|
AG-45A-0019YEK-KI01
|
mouse
|
ELISA
|
|
0.125 to 8ng/ml
|
60pg/ml
|
96 wells
|
||
|
182-HK404-02
|
human
|
ELISA
|
|
102-25,000 pg/ml
|
102 pg/ml
|
2 x 96 det.
|
||
|
182-HIT503
|
|
ELISA
|
|
15.6 to 1000 AU/ml
|
15.6 AU/ml
|
1 x 96 det.
|
||
|
182-HK406-02
|
human
|
ELISA
|
|
47 to 3,000 pg/ml
|
20 pg/ml
|
2 x 96 det.
|
||
|
182-HK501-01
|
|
ELISA
|
|
2 - 1,500 nM
|
2 nM
|
1 x 96 det.
|
||
|
AG-45A-0018YEK-KI01
|
human
|
ELISA
|
|
0.063 to 4ng/ml
|
32pg/ml
|
96 wells
|
||
|
AG-45A-0029YEK-KI01
|
human
|
ELISA
|
|
0.032 to 2ng/ml
|
30pg/ml
|
96 wells
|
||
|
182-HK386-02
|
human
|
ELISA
|
|
1.6-100 ng/ml
|
|
2 x 96 det.
|
||
|
AG-46B-0008-KI01
|
human
|
ELISA
|
|
0.0156 to 1 ng/ml
|
100 pg/ml
|
1 Set
|
||
|
AG-45A-0016YEK-KI01
|
human
|
ELISA
|
|
1.56 to 100ng/ml
|
1.2ng/ml
|
96 wells
|
||
|
AG-48B-1000-KI01
|
human
|
ELISA
|
|
0.9375 to 60 ng/ml
|
0.23 ng/ml
|
96 wells
|
||
|
CY-8077
|
mouse
|
ELISA
|
|
Results exceeding FABP4/AFABP level of 1,000 ng/ml should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the FABP4/AFABP concentration.
|
better than 34.4 pg/ml of sample.
|
96 Assays
|
||
|
CY-8064
|
human
|
ELISA
|
|
|
|
96 Assays
|
||
|
CY-8067
|
mouse
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the antitoCML antibody concentration. Results exceeding antitoCML autoantibody level of 2000 ng/ml, sample should be repeated with dilution buffer.
|
better than 0.162 ng/mL of sample.
|
96 Assays
|
||
|
CY-8099
|
human
|
ELISA
|
|
62.5 pg/mL to 4,000 pg/mL
|
better than 40.0 pg/mL of sample.
|
96 Assays
|
||
|
CY-8062
|
human
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the human S100A9/MRP14 concentration. Results exceeding human S100A9/MRP14 level of 16 ng/ml should be repeated with diluted samples.
|
better than 6.55 pg/ml of sample.
|
96 Assays
|
||
|
CY-8071
|
human
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the Human CRP concentration.
Results exceeding Human CRP level of 9.5 μg/ml should be repeated with diluted samples.
|
better than 28.6 pg/mL of sample.
|
96 Assays
|
||
|
CY-8073
|
human
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the human S100A7/Psoriasin concentration. Results exceeding human S100A7/Psoriasin level of 90 ng/ml should be repeated with diluted samples.
|
better than 0.12 ng/ml of sample.
|
96 Assays
|
||
|
CY-8078
|
mouse
|
ELISA
|
|
|
better than 38.1 pg/ml of sample.
|
96 Assays
|
||
|
CY-8060
|
human
|
ELISA
|
|
Results exceeding S100P level of 5 ng/ml should be repeated with diluted samples. Dilution factors need
to be taken into consideration in calculating the S100P concentration.
|
better than 0.2 ng/ml of sample.
|
96 Assays
|
||
|
CY-8097
|
human
|
ELISA
|
|
37.5 pg/mL～24 ng/mL
|
11.1 pg/mL
|
96 Assays
|
||
|
861.060.020
|
mouse
|
ELISA
|
|
|
|
20 x 96
|
||
|
182-HK401
|
human
|
ELISA
|
|
102-25,000 pg/ml
|
102 pg/ml
|
1 x 96 det.
|
||
|
182-HK386-01
|
human
|
ELISA
|
|
1.6-100 ng/ml
|
|
1 x 96 det.
|
||
|
182-HK501-02
|
|
ELISA
|
|
2 - 1,500 nM
|
2 nM
|
2 x 96 det.
|
||
|
AG-45A-0004YEK-KI01
|
mouse
|
ELISA
|
|
0.125 to 8ng/ml
|
50pg/ml
|
96 wells
|
||
|
AG-45A-0032YEK-KI01
|
human
|
ELISA
|
|
0.47 to 30ng/ml
|
336pg/ml
|
96 wells
|
||
|
AG-45A-0017YTP-KI01
|
human
|
ELISA
|
|
0.016 to 1ng/ml
|
12pg/ml
|
2 x 96 wells
|
||
|
AG-45A-0043YTP-KI01
|
rat
|
ELISA
|
|
0.063 to 4ng/ml
|
40pg/ml
|
2 x 96 wells
|
||
|
AG-45A-0046YEK-KI01
|
human, monkey, mouse, rat
|
ELISA
|
|
0.001 - 5 µg/ml
|
1ng/ml
|
96 wells
|
||
|
AG-45A-0043YEK-KI01
|
rat
|
ELISA
|
|
0.063 to 4ng/ml
|
40pg/ml
|
96 wells
|
||
|
CY-8063
|
human
|
ELISA
|
|
|
|
96 Assays
|
||
|
CY-8057
|
human
|
ELISA
|
|
|
|
96 Assays
|
||
|
CY-8112
|
human
|
ELISA
|
|
100 - 6,400 pg/mL
|
65 pg/mL -
|
96 Assays
|
||
|
CY-8150
|
|
ELISA
|
|
|
|
96 Assays
|
||
|
CY-9050V2
|
human
|
ELISA
|
|
25 pg/mL to 1,600 pg/mL
|
better than 8.4 pg/mL of sample.
|
96 Assays
|
||
|
CY-8053
|
rat
|
ELISA
|
|
|
better than 6.02 pg/ml of sample.
|
96 Assays
|
||
|
CY-8068
|
human
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the antitoCML antibody concentration.
Results exceeding antitoCMLtoautoantibody level of 2000 ng/ml, the sample should be repeated with
dilution buffer.
|
better than 0.32 ng/mL of sample.
|
96 Assays
|
